Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Sleep Apnea Devices Market By Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, And Others] And Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), And Actigraphy Devices]), By Portability (Portable And Non Portable), By End-User (Hospital & Clinics, Home Healthcare, And Others), and by geography expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and the rising geriatric population base across the globe

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030. The demand for sleep apnea devices is primarily being boosted due to the increasing cases of sleep apnea, and the rising population with obesity. Further, the rising adoption of advanced and innovative technologies, the rising awareness about sleep apnea devices, the increasing geriatric population, and the increasing product launches and approval among others, thereby contribute to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

Sleep Apnea Devices Market Dynamics:

The sleep apnea devices market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of diabetes, asthma, sinusitis, and others.

Diabetes can affect the central control of respiration and upper airway neural reflexes, promoting sleep-disordered and leading to chronic obstructive sleeping disorder which can make a person feel depressed or anxious and can lead to daytime tiredness or sleepiness, thus may need a sleeping device for proper sleep and for preventing depression or anxiety-like symptoms. Further, according to IDF Diabetes Atlas Tenth Edition 2022, in 2022 approximately 537 million adults worldwide (20-79 years) were living with diabetes, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. From the same source, more than 1.2 million children and adolescents (0-19 years) were living with diabetes, in 2022. Thus, the increasing population with diabetes may increase the number of sleep disturbances cases and these patients might need sleep apnea devices to maintain respiration & upper airway neural reflexes to get better sleep, thereby propelling the overall market growth of sleep apnea devices.

According to the sleep foundation April 2023, insufficient sleep may lead to snoring or obstructive sleep disorder and can create an economic impact on a person’s life. To control this economic impact people need proper sleep at night so they can give proper attention to their work during the day. For this, people may need sleep apnea devices at the night. Thus, the increasing cases of insomnia will lead to an increased number of snoring or obstructive sleep disorder, ultimately increasing the demand for sleep apnea devices during the forecast year.

Sleep apnea can occur at any age, but adults older than 60 years are at a higher risk of developing this disease as aging is associated with the increasing prevalence of psychosocial factors which affect sleep. Thus, the increasing geriatric population will increase the demand for sleep apnea devices. For instance, as per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world’s population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally.

Further, sleep disturbance is more common in older adults because as the body ages the muscles get weakened and may lead to a collapsible airway, leading to nighttime snoring. Snoring happens when the muscles in the tongue, the roof of a person’s mouth, and the throat relax which constricts airflow, and a person can’t get a full breath. Sleep apnea devices are either attached to the nose or mouth to increase the amount of air that can pass through the throat and help in sleep without snoring. Thus, the increasing geriatric population will increase the need for sleep apnea devices to prevent snoring and sleep apnea. Henceforth, the increasing geriatric population may increase the demand for sleep apnea devices during the forecast period.

Therefore, the above-mentioned factors are contributing to the growth of the sleep apnea devices market during the forecast period from 2024-2030.

However, the high cost of positive airway pressure (PAP) devices, complications due to implantable devices, and others may restrict the sleep apnea devices market growth.

The sleep apnea device market was slightly significantly impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits for treatment and surgical procedures. Further, the treatment of patients suffering from chronic diseases such as asthma, diabetes, cardiovascular disorders, sleeping disorder, and others was not a priority as compared to the covid-19 infection. Additionally, the restrictions in the supply chain, raw materials, and other resources halted the manufacture. However, the demand increased significantly with the availability of sleep apnea devices over e-commerce platforms. This led to an increase in the manufacturing of sleep apnea devices. Also, the sleep apnea device provided treatment to patients in a homecare setting, thereby avoiding frequent visits to healthcare professionals. Henceforth, the afore-said factors propelled the demand for sleep apnea devices during the pandemic and are estimated to grow similarly during the forecast period.

Sleep Apnea Devices Market Segment Analysis:

Sleep Apnea Devices Market by Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, and Others], Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), and Actigraphy Devices]), Portability (Portable and Non-Portable), End-User (Hospital & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the sleep apnea devices market, the positive airway pressure (PAP) device category is expected to amass significant revenue share in the year 2023.

The PAP devices improve sleep quality, lower the risk of heart attack and stroke, and reduces daytime sleepiness. The device eliminates snoring and prevents sleep apnea.

The advantages of the PAP devices over other devices include less discomfort, being non-invasive, and being portable. PAP devices are likely to be the best treatment option in the management of obstructive sleep apnea.

The rising product launches and approvals will create a positive impact on the demand for PAP devices. For instance, in 2022, ResMed launched a new therapeutic air sense 11 PAP (positive airway pressure) device for sleep apnea which provides continuous air pressure to keep the upper airway open and make breathing easy. Many such developments are taking place that includes product launches and approvals, and collaborations, that can boost the segment demand in the upcoming years.

Therefore, the advantages and applications offered by PAP devices are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall sleep apnea devices market during the forecast period.

North America is expected to dominate the overall Sleep Apnea Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sleep apnea devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep apnea and insomnia, the rising geriatric population base in the region, and the rising chronic nasal congestion, are driving the North American sleep apnea devices market and are expected to witness positive growth in the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea devices will also help the market growth in this region.

As per the Centers for Disease and Prevention Control (CDC) 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. A greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8% of those aged 18–44) compared with adults aged 45–64 (21.8%). Thus, people who suffer from any sleep problem due to some other disease can lead to insomnia ultimately they may also feel depression, anxiety, daytime tiredness or sleepiness, and other symptoms which may further lead to breathing disorders and snoring while sleeping. Snoring occurs when pharyngeal muscle tone is lowered during sleep, further reducing the cross-sectional area of the pharynx and leading to increased upper airway resistance. Snoring is often associated with a sleep disorder called obstructive sleep apnea (OSA). Thus, to control this condition of snoring person need a sleep apnea device people may need sleep apnea devices, ultimately increasing the demand for sleep apnea devices and thereby propelling the overall market in the North America region.

According to the CDC 2023, in 2022, 8.0% of people in the US aged 18 and over had asthma. As per the same source, the annual number of hospital visits for asthma was 4.9 million, in 2022, in the US. Asthma causes inflammation and narrowing of the airways, which can trigger irritation and constriction of the small airways which can lead to sleep deprivation. Thus, to maintain these cases of sleep deprivation due to asthma sleep apnea devices can be used. These devices involve wearing a nasal or face mask attached to a machine that delivers continuous air pressure to keep the upper airway open and make breathing easy. Thus, by wearing this device asthma patients can take proper sleep and prevent themselves from sleep deprivation. Hence, increasing cases of asthma will lead to an increase in the demand for sleep apnea devices.

Thus, the aforementioned factors will increase the demand for sleep apnea devices, thereby driving the North American sleep apnea devices market forward during the forecast period.

Sleep Apnea Devices Market Key Players:

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Recent Developmental Activities in the Sleep Apnea Devices Market:

In October 2022, Airway Management, announced the launch of flexTAP, a premium lab-made oral appliance, which is designed to treat patients with snoring and mild to moderate obstructive sleep apnea.

In August 2022, Vivos Therapeutics, Inc, received FDA approval for intraoral devices used for snoring and obstructive sleep apnea.

In March 2020, the FDA approved, eXciteOSA by signifier medical technologies, a neuromuscular tongue muscle stimulator for the reduction of snoring and obstructive sleep apnea.

Key Takeaways from the Sleep Apnea Devices Market Report Study

Market size analysis for current sleep apnea devices market size (2023), and market forecast for 6 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sleep apnea devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global sleep apnea devices market.

Various opportunities are available for the other competitor in the sleep apnea devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sleep apnea devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sleep apnea devices market growth in the coming future?

Target Audience who can be benefited from this Sleep Apnea Devices Market Report Study

Sleep apnea devices products providers

Research organizations and consulting companies

Sleep apnea devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sleep apnea devices

Various End-users who want to know more about the sleep apnea devices market and the latest technological developments in the sleep apnea devices market

Frequently Asked Questions for the Sleep Apnea Devices Market:

1. What is a sleep apnea device?

Sleep apnea device is one of the most common therapies for obstructive sleep apnea. It keeps airways open while sleeping so a person can receive oxygen properly. Sleep apnea devices can significantly improve sleep quality and reduce the risk of several health issues.

2. What is the market for global sleep apnea devices?

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030.

3. What are the drivers for the global sleep apnea devices market?

The demand for sleep apnea devices is primarily being heightened by the increasing prevalence of obstructive sleep apnea disorders and the increasing chronic diseases which lead to sleep disturbance. In addition, the advancement in sleep apnea devices, the increasing device launches, and approvals among others are thereby contributing to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sleep apnea devices market?

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

5. Which region has the highest share in the sleep apnea devices market?

North America is expected to dominate the overall sleep apnea devices market during the forecast period from 2024-2030. Factors such as the rising geriatric population, the rising cases of obesity, the increasing cases of insomnia, and others will propel the demand for sleep apnea devices in North America. Furthermore, increasing technological advancement, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea diseases also helped the market growth in this region.